INCA33890
INCA 33890-101
Phase 1 small_molecule active
Quick answer
INCA33890 for Solid Tumors is a Phase 1 program (small_molecule) at Incyte with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active